TABLE 2.
Liver Biochemistries of Patients
| Patient No. | Disease Control Diagnosis | Age (years) | Sex | Total Bilirubin (mg/dL) | ALT (IU/L) | AST (IU/L) |
|---|---|---|---|---|---|---|
| 1 | Hepatoblastoma | 3.32 | Female | 0.40 | 29 | 27 |
| 2 | Hepatoblastoma | 3.39 | Male | 0.20 | 46 | 63 |
| 3 | Methylmalonic acidemia | 1.65 | Female | 0.60 | 22 | 61 |
| 4 | Ornithine transcarbamylase deficiency | 2.56 | Female | 0.30 | 312 | 331 |
| PNAC Group Diagnosis | Age (years) | Sex | Total Bilirubin (mg/dL) | ALT (IU/L) | AST (IU/L) | |
| 5 | PNAC | 0.10 | Female | 12.10 | 101.00 | 118.00 |
| 6 | PNAC | 0.25 | Female | 8.30 | 226.00 | 213.00 |
| 7 | PNAC | 0.08 | Male | 4.00 | 48.00 | 82.00 |
| 8 | PNAC | 1.02 | Male | 63.2 | 172 | 430.00 |
| 9 | PNAC | 0.18 | Female | 4.80 | 182.00 | 230.00 |
| 10 | PNAC | 0.30 | Female | 5.70 | 36.00 | 70.00 |
| 11 | PNAC | 0.50 | Male | 2.90 | 485.00 | 396.00 |
| Group | Total Bilirubin (mg/dL) (mean ± SEM) | ALT (IU/L) (mean ± SEM) | AST (IU/L) (mean ± SEM) | |||
|
| ||||||
| Disease controls | 0.38 ±0.09 | 102.25 ± 70.10 | 120.50 ± 70.65 | |||
| PNAC | 14.43 ± 8.21 | 178.57 ± 57.65 | 219.86 ± 55.03 | |||
| Liver Biochemistry | Disease Controls vs. PNAC P Value | |||||
|
| ||||||
| Total bilirubin | <0.0001 | |||||
| ALT | ns | |||||
| AST | ns | |||||
Abbreviation: ns, not significant.